nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Amine-derived hormones—TH—epilepsy syndrome	0.0106	0.0634	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—NT5E—epilepsy syndrome	0.00957	0.0574	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—BMP4—epilepsy syndrome	0.00564	0.0338	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—EPO—epilepsy syndrome	0.0056	0.0336	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—GLUD1—epilepsy syndrome	0.00559	0.0335	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—WARS—epilepsy syndrome	0.00525	0.0315	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—GAMT—epilepsy syndrome	0.00511	0.0306	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—EPO—epilepsy syndrome	0.00484	0.029	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—QDPR—epilepsy syndrome	0.00475	0.0285	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—SLC6A8—epilepsy syndrome	0.00424	0.0254	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—ALDH7A1—epilepsy syndrome	0.00306	0.0184	CbGpPWpGaD
Carbimazole—CYP19A1—Endogenous sterols—CYP11A1—epilepsy syndrome	0.003	0.018	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—GLUL—epilepsy syndrome	0.00288	0.0173	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—FOS—epilepsy syndrome	0.0028	0.0168	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.00245	0.0147	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—epilepsy syndrome	0.00225	0.0135	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—FGF2—epilepsy syndrome	0.00214	0.0128	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—epilepsy syndrome	0.00207	0.0124	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.0018	0.0108	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—BDNF—epilepsy syndrome	0.00173	0.0104	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—epilepsy syndrome	0.00152	0.0091	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—VDR—epilepsy syndrome	0.00148	0.00888	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—TH—epilepsy syndrome	0.00147	0.00884	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.0014	0.0084	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.00139	0.00835	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—TSC2—epilepsy syndrome	0.00139	0.00832	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.00138	0.00829	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.00137	0.00824	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CA13—epilepsy syndrome	0.00135	0.00812	CbGpPWpGaD
Carbimazole—CYP19A1—Endogenous sterols—POMC—epilepsy syndrome	0.00133	0.00795	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.00126	0.00753	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.00124	0.00744	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—ATM—epilepsy syndrome	0.00114	0.00684	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CAT—epilepsy syndrome	0.00114	0.00684	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.00114	0.00681	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.00113	0.00677	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PDXK—epilepsy syndrome	0.00103	0.00615	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GLUD1—epilepsy syndrome	0.00103	0.00615	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADK—epilepsy syndrome	0.00103	0.00615	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FAR1—epilepsy syndrome	0.00103	0.00615	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CERS1—epilepsy syndrome	0.00103	0.00615	CbGpPWpGaD
Carbimazole—TPO—Metabolism—L2HGDH—epilepsy syndrome	0.00103	0.00615	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.00102	0.00611	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—epilepsy syndrome	0.000993	0.00595	CbGpPWpGaD
Carbimazole—Urticaria—Propofol—epilepsy syndrome	0.00096	0.00115	CcSEcCtD
Carbimazole—Skin disorder—Clonazepam—epilepsy syndrome	0.000959	0.00115	CcSEcCtD
Carbimazole—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000957	0.00115	CcSEcCtD
Carbimazole—Body temperature increased—Propofol—epilepsy syndrome	0.000955	0.00115	CcSEcCtD
Carbimazole—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000955	0.00115	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000953	0.00114	CcSEcCtD
Carbimazole—Nausea—Rufinamide—epilepsy syndrome	0.000951	0.00114	CcSEcCtD
Carbimazole—Rash—Lacosamide—epilepsy syndrome	0.000948	0.00114	CcSEcCtD
Carbimazole—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000947	0.00114	CcSEcCtD
Carbimazole—Dermatitis—Lacosamide—epilepsy syndrome	0.000947	0.00114	CcSEcCtD
Carbimazole—Arthralgia—Lamotrigine—epilepsy syndrome	0.000944	0.00113	CcSEcCtD
Carbimazole—Myalgia—Lamotrigine—epilepsy syndrome	0.000944	0.00113	CcSEcCtD
Carbimazole—Headache—Lacosamide—epilepsy syndrome	0.000942	0.00113	CcSEcCtD
Carbimazole—Liver function test abnormal—Topiramate—epilepsy syndrome	0.000942	0.00113	CcSEcCtD
Carbimazole—Urticaria—Midazolam—epilepsy syndrome	0.000939	0.00113	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—MTOR—epilepsy syndrome	0.000939	0.00563	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PNPO—epilepsy syndrome	0.000939	0.00563	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NHLRC1—epilepsy syndrome	0.000939	0.00563	CbGpPWpGaD
Carbimazole—TPO—Metabolism—EPM2A—epilepsy syndrome	0.000939	0.00563	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GAMT—epilepsy syndrome	0.000939	0.00563	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.000933	0.00112	CcSEcCtD
Carbimazole—Discomfort—Lamotrigine—epilepsy syndrome	0.000932	0.00112	CcSEcCtD
Carbimazole—Infection—Carbamazepine—epilepsy syndrome	0.00093	0.00112	CcSEcCtD
Carbimazole—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.000928	0.00111	CcSEcCtD
Carbimazole—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000923	0.00111	CcSEcCtD
Carbimazole—Rash—Clobazam—epilepsy syndrome	0.00092	0.0011	CcSEcCtD
Carbimazole—Dermatitis—Clobazam—epilepsy syndrome	0.000919	0.0011	CcSEcCtD
Carbimazole—Haemoglobin—Pregabalin—epilepsy syndrome	0.000919	0.0011	CcSEcCtD
Carbimazole—Angiopathy—Valproic Acid—epilepsy syndrome	0.000918	0.0011	CcSEcCtD
Carbimazole—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000918	0.0011	CcSEcCtD
Carbimazole—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000916	0.0011	CcSEcCtD
Carbimazole—Hepatitis—Pregabalin—epilepsy syndrome	0.000915	0.0011	CcSEcCtD
Carbimazole—Haemorrhage—Pregabalin—epilepsy syndrome	0.000915	0.0011	CcSEcCtD
Carbimazole—Headache—Clobazam—epilepsy syndrome	0.000914	0.0011	CcSEcCtD
Carbimazole—Stomatitis—Gabapentin—epilepsy syndrome	0.000911	0.00109	CcSEcCtD
Carbimazole—Jaundice—Gabapentin—epilepsy syndrome	0.000911	0.00109	CcSEcCtD
Carbimazole—Skin disorder—Carbamazepine—epilepsy syndrome	0.000909	0.00109	CcSEcCtD
Carbimazole—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000905	0.00109	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000899	0.00108	CcSEcCtD
Carbimazole—Infection—Lamotrigine—epilepsy syndrome	0.000899	0.00108	CcSEcCtD
Carbimazole—Urticaria—Fosphenytoin—epilepsy syndrome	0.000895	0.00107	CcSEcCtD
Carbimazole—Alopecia—Valproic Acid—epilepsy syndrome	0.000894	0.00107	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000893	0.00107	CcSEcCtD
Carbimazole—Nausea—Lacosamide—epilepsy syndrome	0.000893	0.00107	CcSEcCtD
Carbimazole—Feeling abnormal—Diazepam—epilepsy syndrome	0.000891	0.00107	CcSEcCtD
Carbimazole—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000891	0.00107	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000889	0.00107	CcSEcCtD
Carbimazole—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000887	0.00106	CcSEcCtD
Carbimazole—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000886	0.00106	CcSEcCtD
Carbimazole—Eosinophilia—Topiramate—epilepsy syndrome	0.000873	0.00105	CcSEcCtD
Carbimazole—TPO—Metabolism—CA4—epilepsy syndrome	0.000873	0.00523	CbGpPWpGaD
Carbimazole—TPO—Metabolism—QDPR—epilepsy syndrome	0.000873	0.00523	CbGpPWpGaD
Carbimazole—Urticaria—Vigabatrin—epilepsy syndrome	0.000872	0.00105	CcSEcCtD
Carbimazole—Hypersensitivity—Midazolam—epilepsy syndrome	0.000871	0.00105	CcSEcCtD
Carbimazole—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000868	0.00104	CcSEcCtD
Carbimazole—Nausea—Clobazam—epilepsy syndrome	0.000867	0.00104	CcSEcCtD
Carbimazole—Feeling abnormal—Felbamate—epilepsy syndrome	0.000862	0.00104	CcSEcCtD
Carbimazole—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00086	0.00103	CcSEcCtD
Carbimazole—Urticaria—Diazepam—epilepsy syndrome	0.000859	0.00103	CcSEcCtD
Carbimazole—Pruritus—Propofol—epilepsy syndrome	0.000855	0.00103	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000853	0.00102	CcSEcCtD
Carbimazole—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000844	0.00101	CcSEcCtD
Carbimazole—Haemorrhage—Gabapentin—epilepsy syndrome	0.000839	0.00101	CcSEcCtD
Carbimazole—Hepatitis—Gabapentin—epilepsy syndrome	0.000839	0.00101	CcSEcCtD
Carbimazole—Pancytopenia—Topiramate—epilepsy syndrome	0.000837	0.001	CcSEcCtD
Carbimazole—Pruritus—Midazolam—epilepsy syndrome	0.000836	0.001	CcSEcCtD
Carbimazole—Urticaria—Felbamate—epilepsy syndrome	0.000831	0.000998	CcSEcCtD
Carbimazole—Angiopathy—Pregabalin—epilepsy syndrome	0.00083	0.000996	CcSEcCtD
Carbimazole—Body temperature increased—Felbamate—epilepsy syndrome	0.000827	0.000993	CcSEcCtD
Carbimazole—Pruritus—Levetiracetam—epilepsy syndrome	0.000826	0.000991	CcSEcCtD
Carbimazole—Neutropenia—Topiramate—epilepsy syndrome	0.000824	0.000989	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000824	0.000989	CcSEcCtD
Carbimazole—TPO—Metabolism—COX3—epilepsy syndrome	0.000821	0.00492	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Valproic Acid—epilepsy syndrome	0.000817	0.000981	CcSEcCtD
Carbimazole—Headache—Acetazolamide—epilepsy syndrome	0.000815	0.000978	CcSEcCtD
Carbimazole—Urticaria—Zonisamide—epilepsy syndrome	0.000814	0.000977	CcSEcCtD
Carbimazole—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000814	0.000976	CcSEcCtD
Carbimazole—Body temperature increased—Zonisamide—epilepsy syndrome	0.00081	0.000972	CcSEcCtD
Carbimazole—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000809	0.000971	CcSEcCtD
Carbimazole—Alopecia—Pregabalin—epilepsy syndrome	0.000808	0.00097	CcSEcCtD
Carbimazole—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000808	0.00097	CcSEcCtD
Carbimazole—Angioedema—Valproic Acid—epilepsy syndrome	0.000805	0.000966	CcSEcCtD
Carbimazole—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000804	0.000965	CcSEcCtD
Carbimazole—Pruritus—Fosphenytoin—epilepsy syndrome	0.000797	0.000957	CcSEcCtD
Carbimazole—Hypersensitivity—Diazepam—epilepsy syndrome	0.000797	0.000956	CcSEcCtD
Carbimazole—Malaise—Valproic Acid—epilepsy syndrome	0.000794	0.000953	CcSEcCtD
Carbimazole—Leukopenia—Valproic Acid—epilepsy syndrome	0.000788	0.000946	CcSEcCtD
Carbimazole—Urticaria—Clonazepam—epilepsy syndrome	0.000784	0.000941	CcSEcCtD
Carbimazole—Body temperature increased—Clonazepam—epilepsy syndrome	0.00078	0.000937	CcSEcCtD
Carbimazole—Urticaria—Phenytoin—epilepsy syndrome	0.000779	0.000935	CcSEcCtD
Carbimazole—TPO—Metabolism—CACNA2D2—epilepsy syndrome	0.000778	0.00466	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC6A8—epilepsy syndrome	0.000778	0.00466	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLCO1A2—epilepsy syndrome	0.000778	0.00466	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PFKL—epilepsy syndrome	0.000778	0.00466	CbGpPWpGaD
Carbimazole—TPO—Metabolism—KCNB1—epilepsy syndrome	0.000778	0.00466	CbGpPWpGaD
Carbimazole—Pruritus—Vigabatrin—epilepsy syndrome	0.000777	0.000933	CcSEcCtD
Carbimazole—Body temperature increased—Phenytoin—epilepsy syndrome	0.000775	0.00093	CcSEcCtD
Carbimazole—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000775	0.00093	CcSEcCtD
Carbimazole—Nausea—Acetazolamide—epilepsy syndrome	0.000773	0.000927	CcSEcCtD
Carbimazole—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000771	0.000926	CcSEcCtD
Carbimazole—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000771	0.000925	CcSEcCtD
Carbimazole—Stomatitis—Topiramate—epilepsy syndrome	0.000766	0.00092	CcSEcCtD
Carbimazole—Pruritus—Diazepam—epilepsy syndrome	0.000765	0.000918	CcSEcCtD
Carbimazole—Rash—Propofol—epilepsy syndrome	0.000762	0.000914	CcSEcCtD
Carbimazole—Dermatitis—Propofol—epilepsy syndrome	0.000761	0.000914	CcSEcCtD
Carbimazole—Headache—Propofol—epilepsy syndrome	0.000757	0.000909	CcSEcCtD
Carbimazole—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000755	0.000906	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—SRC—epilepsy syndrome	0.000752	0.00451	CbGpPWpGaD
Carbimazole—Myalgia—Valproic Acid—epilepsy syndrome	0.00075	0.0009	CcSEcCtD
Carbimazole—Arthralgia—Valproic Acid—epilepsy syndrome	0.00075	0.0009	CcSEcCtD
Carbimazole—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000745	0.000895	CcSEcCtD
Carbimazole—Rash—Midazolam—epilepsy syndrome	0.000745	0.000895	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000745	0.000894	CcSEcCtD
Carbimazole—Dermatitis—Midazolam—epilepsy syndrome	0.000745	0.000894	CcSEcCtD
Carbimazole—Urticaria—Carbamazepine—epilepsy syndrome	0.000744	0.000892	CcSEcCtD
Carbimazole—Alopecia—Gabapentin—epilepsy syndrome	0.000741	0.00089	CcSEcCtD
Carbimazole—Discomfort—Valproic Acid—epilepsy syndrome	0.000741	0.000889	CcSEcCtD
Carbimazole—Headache—Midazolam—epilepsy syndrome	0.000741	0.000889	CcSEcCtD
Carbimazole—Pruritus—Felbamate—epilepsy syndrome	0.00074	0.000889	CcSEcCtD
Carbimazole—Body temperature increased—Carbamazepine—epilepsy syndrome	0.00074	0.000888	CcSEcCtD
Carbimazole—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000739	0.000887	CcSEcCtD
Carbimazole—Rash—Levetiracetam—epilepsy syndrome	0.000736	0.000883	CcSEcCtD
Carbimazole—Dermatitis—Levetiracetam—epilepsy syndrome	0.000735	0.000883	CcSEcCtD
Carbimazole—Agranulocytosis—Topiramate—epilepsy syndrome	0.000734	0.00088	CcSEcCtD
Carbimazole—Headache—Levetiracetam—epilepsy syndrome	0.000731	0.000878	CcSEcCtD
Carbimazole—Angioedema—Pregabalin—epilepsy syndrome	0.000728	0.000873	CcSEcCtD
Carbimazole—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000727	0.000873	CcSEcCtD
Carbimazole—Pruritus—Zonisamide—epilepsy syndrome	0.000725	0.00087	CcSEcCtD
Carbimazole—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000722	0.000867	CcSEcCtD
Carbimazole—Urticaria—Lamotrigine—epilepsy syndrome	0.000719	0.000863	CcSEcCtD
Carbimazole—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000719	0.000863	CcSEcCtD
Carbimazole—Malaise—Pregabalin—epilepsy syndrome	0.000718	0.000862	CcSEcCtD
Carbimazole—Nausea—Propofol—epilepsy syndrome	0.000718	0.000861	CcSEcCtD
Carbimazole—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000715	0.000858	CcSEcCtD
Carbimazole—Infection—Valproic Acid—epilepsy syndrome	0.000714	0.000857	CcSEcCtD
Carbimazole—Leukopenia—Pregabalin—epilepsy syndrome	0.000713	0.000855	CcSEcCtD
Carbimazole—TPO—Metabolism—ATIC—epilepsy syndrome	0.000711	0.00426	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UPB1—epilepsy syndrome	0.000711	0.00426	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NEU1—epilepsy syndrome	0.000711	0.00426	CbGpPWpGaD
Carbimazole—Rash—Fosphenytoin—epilepsy syndrome	0.00071	0.000853	CcSEcCtD
Carbimazole—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00071	0.000852	CcSEcCtD
Carbimazole—Haemoglobin—Topiramate—epilepsy syndrome	0.000709	0.000851	CcSEcCtD
Carbimazole—Headache—Fosphenytoin—epilepsy syndrome	0.000706	0.000847	CcSEcCtD
Carbimazole—Hepatitis—Topiramate—epilepsy syndrome	0.000706	0.000847	CcSEcCtD
Carbimazole—Haemorrhage—Topiramate—epilepsy syndrome	0.000706	0.000847	CcSEcCtD
Carbimazole—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000705	0.000846	CcSEcCtD
Carbimazole—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000704	0.000845	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000702	0.00421	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000702	0.00421	CbGpPWpGaD
Carbimazole—Nausea—Midazolam—epilepsy syndrome	0.000702	0.000843	CcSEcCtD
Carbimazole—Pruritus—Clonazepam—epilepsy syndrome	0.000698	0.000838	CcSEcCtD
Carbimazole—Skin disorder—Valproic Acid—epilepsy syndrome	0.000698	0.000838	CcSEcCtD
Carbimazole—Pruritus—Phenytoin—epilepsy syndrome	0.000694	0.000833	CcSEcCtD
Carbimazole—Nausea—Levetiracetam—epilepsy syndrome	0.000693	0.000832	CcSEcCtD
Carbimazole—Rash—Vigabatrin—epilepsy syndrome	0.000692	0.000831	CcSEcCtD
Carbimazole—Dermatitis—Vigabatrin—epilepsy syndrome	0.000692	0.00083	CcSEcCtD
Carbimazole—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00069	0.000828	CcSEcCtD
Carbimazole—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.00069	0.000828	CcSEcCtD
Carbimazole—Headache—Vigabatrin—epilepsy syndrome	0.000688	0.000826	CcSEcCtD
Carbimazole—TPO—Metabolism—HSD17B4—epilepsy syndrome	0.000685	0.00411	CbGpPWpGaD
Carbimazole—Rash—Diazepam—epilepsy syndrome	0.000682	0.000818	CcSEcCtD
Carbimazole—Dermatitis—Diazepam—epilepsy syndrome	0.000681	0.000817	CcSEcCtD
Carbimazole—Arthralgia—Pregabalin—epilepsy syndrome	0.000678	0.000814	CcSEcCtD
Carbimazole—Myalgia—Pregabalin—epilepsy syndrome	0.000678	0.000814	CcSEcCtD
Carbimazole—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000677	0.000813	CcSEcCtD
Carbimazole—Headache—Diazepam—epilepsy syndrome	0.000677	0.000813	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000673	0.000808	CcSEcCtD
Carbimazole—Discomfort—Pregabalin—epilepsy syndrome	0.00067	0.000804	CcSEcCtD
Carbimazole—Nausea—Fosphenytoin—epilepsy syndrome	0.000669	0.000803	CcSEcCtD
Carbimazole—Angioedema—Gabapentin—epilepsy syndrome	0.000667	0.000801	CcSEcCtD
Carbimazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000667	0.0008	CcSEcCtD
Carbimazole—Pruritus—Carbamazepine—epilepsy syndrome	0.000662	0.000795	CcSEcCtD
Carbimazole—TPO—Metabolism—GBE1—epilepsy syndrome	0.000661	0.00396	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPP1R3C—epilepsy syndrome	0.000661	0.00396	CbGpPWpGaD
Carbimazole—Rash—Felbamate—epilepsy syndrome	0.00066	0.000792	CcSEcCtD
Carbimazole—Dermatitis—Felbamate—epilepsy syndrome	0.000659	0.000791	CcSEcCtD
Carbimazole—Malaise—Gabapentin—epilepsy syndrome	0.000658	0.00079	CcSEcCtD
Carbimazole—Headache—Felbamate—epilepsy syndrome	0.000656	0.000787	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000655	0.000786	CcSEcCtD
Carbimazole—Leukopenia—Gabapentin—epilepsy syndrome	0.000654	0.000784	CcSEcCtD
Carbimazole—Nausea—Vigabatrin—epilepsy syndrome	0.000652	0.000783	CcSEcCtD
Carbimazole—Rash—Zonisamide—epilepsy syndrome	0.000646	0.000775	CcSEcCtD
Carbimazole—Infection—Pregabalin—epilepsy syndrome	0.000646	0.000775	CcSEcCtD
Carbimazole—Dermatitis—Zonisamide—epilepsy syndrome	0.000645	0.000774	CcSEcCtD
Carbimazole—Nausea—Diazepam—epilepsy syndrome	0.000642	0.000771	CcSEcCtD
Carbimazole—Headache—Zonisamide—epilepsy syndrome	0.000642	0.00077	CcSEcCtD
Carbimazole—Angiopathy—Topiramate—epilepsy syndrome	0.00064	0.000768	CcSEcCtD
Carbimazole—Pruritus—Lamotrigine—epilepsy syndrome	0.00064	0.000768	CcSEcCtD
Carbimazole—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000637	0.000765	CcSEcCtD
Carbimazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000636	0.000764	CcSEcCtD
Carbimazole—Skin disorder—Pregabalin—epilepsy syndrome	0.000631	0.000758	CcSEcCtD
Carbimazole—Alopecia—Topiramate—epilepsy syndrome	0.000624	0.000748	CcSEcCtD
Carbimazole—Rash—Clonazepam—epilepsy syndrome	0.000622	0.000747	CcSEcCtD
Carbimazole—Dermatitis—Clonazepam—epilepsy syndrome	0.000622	0.000746	CcSEcCtD
Carbimazole—TPO—Metabolism—ASAH1—epilepsy syndrome	0.000622	0.00373	CbGpPWpGaD
Carbimazole—Arthralgia—Gabapentin—epilepsy syndrome	0.000622	0.000746	CcSEcCtD
Carbimazole—Myalgia—Gabapentin—epilepsy syndrome	0.000622	0.000746	CcSEcCtD
Carbimazole—Nausea—Felbamate—epilepsy syndrome	0.000622	0.000746	CcSEcCtD
Carbimazole—Headache—Clonazepam—epilepsy syndrome	0.000618	0.000742	CcSEcCtD
Carbimazole—Rash—Phenytoin—epilepsy syndrome	0.000618	0.000742	CcSEcCtD
Carbimazole—Dermatitis—Phenytoin—epilepsy syndrome	0.000618	0.000741	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000617	0.000741	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.000616	0.00369	CbGpPWpGaD
Carbimazole—Rash—Oxcarbazepine—epilepsy syndrome	0.000615	0.000738	CcSEcCtD
Carbimazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000614	0.000737	CcSEcCtD
Carbimazole—Headache—Phenytoin—epilepsy syndrome	0.000614	0.000737	CcSEcCtD
Carbimazole—Discomfort—Gabapentin—epilepsy syndrome	0.000614	0.000737	CcSEcCtD
Carbimazole—Headache—Oxcarbazepine—epilepsy syndrome	0.000611	0.000733	CcSEcCtD
Carbimazole—Nausea—Zonisamide—epilepsy syndrome	0.000608	0.00073	CcSEcCtD
Carbimazole—TPO—Metabolism—STXBP1—epilepsy syndrome	0.000605	0.00363	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.000603	0.00362	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TSC1—epilepsy syndrome	0.000601	0.0036	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.0006	0.00359	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000595	0.00357	CbGpPWpGaD
Carbimazole—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000592	0.000711	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000592	0.000711	CcSEcCtD
Carbimazole—Infection—Gabapentin—epilepsy syndrome	0.000592	0.000711	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000591	0.00355	CbGpPWpGaD
Carbimazole—Rash—Carbamazepine—epilepsy syndrome	0.00059	0.000708	CcSEcCtD
Carbimazole—Dermatitis—Carbamazepine—epilepsy syndrome	0.00059	0.000708	CcSEcCtD
Carbimazole—TPO—Metabolism—NT5E—epilepsy syndrome	0.00059	0.00353	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALAD—epilepsy syndrome	0.00059	0.00353	CbGpPWpGaD
Carbimazole—Nausea—Clonazepam—epilepsy syndrome	0.000586	0.000704	CcSEcCtD
Carbimazole—Headache—Carbamazepine—epilepsy syndrome	0.000586	0.000704	CcSEcCtD
Carbimazole—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000584	0.000701	CcSEcCtD
Carbimazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000583	0.0007	CcSEcCtD
Carbimazole—Nausea—Phenytoin—epilepsy syndrome	0.000582	0.000699	CcSEcCtD
Carbimazole—Nausea—Oxcarbazepine—epilepsy syndrome	0.000579	0.000695	CcSEcCtD
Carbimazole—Skin disorder—Gabapentin—epilepsy syndrome	0.000579	0.000695	CcSEcCtD
Carbimazole—Urticaria—Valproic Acid—epilepsy syndrome	0.000571	0.000685	CcSEcCtD
Carbimazole—Rash—Lamotrigine—epilepsy syndrome	0.00057	0.000685	CcSEcCtD
Carbimazole—Ill-defined disorder—Topiramate—epilepsy syndrome	0.00057	0.000684	CcSEcCtD
Carbimazole—Dermatitis—Lamotrigine—epilepsy syndrome	0.00057	0.000684	CcSEcCtD
Carbimazole—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000568	0.000682	CcSEcCtD
Carbimazole—Headache—Lamotrigine—epilepsy syndrome	0.000567	0.00068	CcSEcCtD
Carbimazole—TPO—Metabolism—CACNA1A—epilepsy syndrome	0.000562	0.00337	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALDH7A1—epilepsy syndrome	0.000562	0.00337	CbGpPWpGaD
Carbimazole—Nausea—Carbamazepine—epilepsy syndrome	0.000556	0.000667	CcSEcCtD
Carbimazole—Malaise—Topiramate—epilepsy syndrome	0.000554	0.000665	CcSEcCtD
Carbimazole—TPO—Metabolism—ST3GAL3—epilepsy syndrome	0.00055	0.0033	CbGpPWpGaD
Carbimazole—Leukopenia—Topiramate—epilepsy syndrome	0.00055	0.00066	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000543	0.000652	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP2D6—epilepsy syndrome	0.000541	0.00324	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADSL—epilepsy syndrome	0.000539	0.00323	CbGpPWpGaD
Carbimazole—Nausea—Lamotrigine—epilepsy syndrome	0.000537	0.000645	CcSEcCtD
Carbimazole—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000536	0.000643	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.000534	0.0032	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000532	0.00319	CbGpPWpGaD
Carbimazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00053	0.000636	CcSEcCtD
Carbimazole—TPO—Metabolism—GLUL—epilepsy syndrome	0.000529	0.00317	CbGpPWpGaD
Carbimazole—Arthralgia—Topiramate—epilepsy syndrome	0.000523	0.000628	CcSEcCtD
Carbimazole—Myalgia—Topiramate—epilepsy syndrome	0.000523	0.000628	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000519	0.000623	CcSEcCtD
Carbimazole—TPO—Metabolism—CACNA1D—epilepsy syndrome	0.000519	0.00311	CbGpPWpGaD
Carbimazole—Discomfort—Topiramate—epilepsy syndrome	0.000517	0.00062	CcSEcCtD
Carbimazole—Urticaria—Pregabalin—epilepsy syndrome	0.000516	0.00062	CcSEcCtD
Carbimazole—Body temperature increased—Pregabalin—epilepsy syndrome	0.000514	0.000617	CcSEcCtD
Carbimazole—Pruritus—Valproic Acid—epilepsy syndrome	0.000509	0.00061	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	0.000499	0.00299	CbGpPWpGaD
Carbimazole—Infection—Topiramate—epilepsy syndrome	0.000498	0.000598	CcSEcCtD
Carbimazole—Nervous system disorder—Topiramate—epilepsy syndrome	0.000492	0.00059	CcSEcCtD
Carbimazole—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000491	0.000589	CcSEcCtD
Carbimazole—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000491	0.000589	CcSEcCtD
Carbimazole—Skin disorder—Topiramate—epilepsy syndrome	0.000487	0.000584	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.000487	0.00292	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TXNRD1—epilepsy syndrome	0.000485	0.00291	CbGpPWpGaD
Carbimazole—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000479	0.000575	CcSEcCtD
Carbimazole—Urticaria—Gabapentin—epilepsy syndrome	0.000473	0.000568	CcSEcCtD
Carbimazole—TPO—Metabolism—AQP1—epilepsy syndrome	0.000471	0.00283	CbGpPWpGaD
Carbimazole—Body temperature increased—Gabapentin—epilepsy syndrome	0.000471	0.000565	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000469	0.00281	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—epilepsy syndrome	0.000468	0.0028	CbGpPWpGaD
Carbimazole—Pruritus—Pregabalin—epilepsy syndrome	0.00046	0.000552	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDC42—epilepsy syndrome	0.000457	0.00274	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000457	0.000548	CcSEcCtD
Carbimazole—Rash—Valproic Acid—epilepsy syndrome	0.000453	0.000544	CcSEcCtD
Carbimazole—Dermatitis—Valproic Acid—epilepsy syndrome	0.000453	0.000543	CcSEcCtD
Carbimazole—Headache—Valproic Acid—epilepsy syndrome	0.00045	0.000541	CcSEcCtD
Carbimazole—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000439	0.000527	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—epilepsy syndrome	0.000434	0.0026	CbGpPWpGaD
Carbimazole—Nausea—Valproic Acid—epilepsy syndrome	0.000427	0.000512	CcSEcCtD
Carbimazole—TPO—Metabolism—KCNJ11—epilepsy syndrome	0.000426	0.00255	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CHRM3—epilepsy syndrome	0.000426	0.00255	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000426	0.00255	CbGpPWpGaD
Carbimazole—Pruritus—Gabapentin—epilepsy syndrome	0.000422	0.000506	CcSEcCtD
Carbimazole—Feeling abnormal—Topiramate—epilepsy syndrome	0.000413	0.000496	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—CA13—epilepsy syndrome	0.000413	0.00247	CbGpPWpGaD
Carbimazole—Rash—Pregabalin—epilepsy syndrome	0.00041	0.000492	CcSEcCtD
Carbimazole—Dermatitis—Pregabalin—epilepsy syndrome	0.000409	0.000491	CcSEcCtD
Carbimazole—Headache—Pregabalin—epilepsy syndrome	0.000407	0.000489	CcSEcCtD
Carbimazole—Urticaria—Topiramate—epilepsy syndrome	0.000398	0.000478	CcSEcCtD
Carbimazole—Body temperature increased—Topiramate—epilepsy syndrome	0.000396	0.000476	CcSEcCtD
Carbimazole—Nausea—Pregabalin—epilepsy syndrome	0.000386	0.000463	CcSEcCtD
Carbimazole—Rash—Gabapentin—epilepsy syndrome	0.000376	0.000451	CcSEcCtD
Carbimazole—Dermatitis—Gabapentin—epilepsy syndrome	0.000375	0.000451	CcSEcCtD
Carbimazole—Headache—Gabapentin—epilepsy syndrome	0.000373	0.000448	CcSEcCtD
Carbimazole—Hypersensitivity—Topiramate—epilepsy syndrome	0.000369	0.000443	CcSEcCtD
Carbimazole—Pruritus—Topiramate—epilepsy syndrome	0.000355	0.000426	CcSEcCtD
Carbimazole—Nausea—Gabapentin—epilepsy syndrome	0.000354	0.000425	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TSC2—epilepsy syndrome	0.00035	0.0021	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG2—epilepsy syndrome	0.000347	0.00208	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2C19—epilepsy syndrome	0.000339	0.00203	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP11A1—epilepsy syndrome	0.000336	0.00202	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000332	0.00199	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ATM—epilepsy syndrome	0.00033	0.00198	CbGpPWpGaD
Carbimazole—Rash—Topiramate—epilepsy syndrome	0.000316	0.000379	CcSEcCtD
Carbimazole—Dermatitis—Topiramate—epilepsy syndrome	0.000316	0.000379	CcSEcCtD
Carbimazole—Headache—Topiramate—epilepsy syndrome	0.000314	0.000377	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—L2HGDH—epilepsy syndrome	0.000313	0.00188	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FAR1—epilepsy syndrome	0.000313	0.00188	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GLUD1—epilepsy syndrome	0.000313	0.00188	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADK—epilepsy syndrome	0.000313	0.00188	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PDXK—epilepsy syndrome	0.000313	0.00188	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CERS1—epilepsy syndrome	0.000313	0.00188	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2D6—epilepsy syndrome	0.000304	0.00182	CbGpPWpGaD
Carbimazole—Nausea—Topiramate—epilepsy syndrome	0.000298	0.000357	CcSEcCtD
Carbimazole—TPO—Metabolism—ADRA2A—epilepsy syndrome	0.000289	0.00173	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—epilepsy syndrome	0.000288	0.00173	CbGpPWpGaD
Carbimazole—TPO—Metabolism—BCHE—epilepsy syndrome	0.000288	0.00173	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GAMT—epilepsy syndrome	0.000286	0.00172	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PNPO—epilepsy syndrome	0.000286	0.00172	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—EPM2A—epilepsy syndrome	0.000286	0.00172	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NHLRC1—epilepsy syndrome	0.000286	0.00172	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC2A1—epilepsy syndrome	0.000275	0.00165	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLCB1—epilepsy syndrome	0.000272	0.00163	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TH—epilepsy syndrome	0.000271	0.00162	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—QDPR—epilepsy syndrome	0.000266	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA4—epilepsy syndrome	0.000266	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—POMC—epilepsy syndrome	0.000265	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—COX3—epilepsy syndrome	0.00025	0.0015	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—epilepsy syndrome	0.000247	0.00148	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLCO1A2—epilepsy syndrome	0.000237	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PFKL—epilepsy syndrome	0.000237	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CACNA2D2—epilepsy syndrome	0.000237	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—KCNB1—epilepsy syndrome	0.000237	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC6A8—epilepsy syndrome	0.000237	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—epilepsy syndrome	0.000237	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.000232	0.00139	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.00023	0.00138	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMOX1—epilepsy syndrome	0.000226	0.00135	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAT—epilepsy syndrome	0.000223	0.00134	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—epilepsy syndrome	0.000218	0.00131	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ATIC—epilepsy syndrome	0.000217	0.0013	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NEU1—epilepsy syndrome	0.000217	0.0013	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCB1—epilepsy syndrome	0.000217	0.0013	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UPB1—epilepsy syndrome	0.000217	0.0013	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—epilepsy syndrome	0.000212	0.00127	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD17B4—epilepsy syndrome	0.000209	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GBE1—epilepsy syndrome	0.000202	0.00121	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPP1R3C—epilepsy syndrome	0.000202	0.00121	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPX1—epilepsy syndrome	0.000202	0.00121	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000197	0.00118	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ASAH1—epilepsy syndrome	0.00019	0.00114	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—epilepsy syndrome	0.000185	0.00111	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—STXBP1—epilepsy syndrome	0.000184	0.00111	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NT5E—epilepsy syndrome	0.00018	0.00108	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALAD—epilepsy syndrome	0.00018	0.00108	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AGT—epilepsy syndrome	0.000177	0.00106	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOE—epilepsy syndrome	0.000173	0.00104	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDH7A1—epilepsy syndrome	0.000171	0.00103	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CACNA1A—epilepsy syndrome	0.000171	0.00103	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ST3GAL3—epilepsy syndrome	0.000168	0.00101	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADSL—epilepsy syndrome	0.000164	0.000985	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GLUL—epilepsy syndrome	0.000161	0.000966	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CACNA1D—epilepsy syndrome	0.000158	0.000948	CbGpPWpGaD
Carbimazole—TPO—Metabolism—POMC—epilepsy syndrome	0.000149	0.000892	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TXNRD1—epilepsy syndrome	0.000148	0.000887	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AQP1—epilepsy syndrome	0.000144	0.000861	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000138	0.000827	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—epilepsy syndrome	0.000136	0.000813	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	0.00013	0.000779	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	0.00013	0.000779	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000121	0.000725	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—epilepsy syndrome	0.000119	0.000711	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000119	0.000711	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	0.000118	0.000707	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	0.000106	0.000635	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	0.000103	0.000619	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	0.000103	0.000615	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000102	0.00061	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.28e-05	0.000556	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	9.26e-05	0.000555	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	8.81e-05	0.000528	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—BCHE—epilepsy syndrome	8.77e-05	0.000526	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	8.37e-05	0.000502	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	8.28e-05	0.000496	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TH—epilepsy syndrome	8.25e-05	0.000495	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.12e-05	0.000487	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	6.89e-05	0.000413	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAT—epilepsy syndrome	6.79e-05	0.000407	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	6.61e-05	0.000396	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX1—epilepsy syndrome	6.14e-05	0.000368	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—epilepsy syndrome	5.96e-05	0.000358	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AGT—epilepsy syndrome	5.39e-05	0.000323	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOE—epilepsy syndrome	5.28e-05	0.000316	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—POMC—epilepsy syndrome	4.53e-05	0.000272	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—epilepsy syndrome	4.13e-05	0.000248	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	3.62e-05	0.000217	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—epilepsy syndrome	1.82e-05	0.000109	CbGpPWpGaD
